• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2001 Fiscal Year Final Research Report Summary

Study of the Regulatory Mechanisms of Macrophage Apoptosis Induced by Lipopolysaccharides

Research Project

Project/Area Number 12672147
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Biological pharmacy
Research InstitutionOsaka University of pharmaceutical Sciences, Assistant (2001)
National Institute of Infectious Diseases (2000)

Principal Investigator

AMANO Fumio  Faclty of Pharm. Sci., Osaka Univ. Pharm. Sci., Professor, 薬学部, 教授 (90142132)

Project Period (FY) 2000 – 2001
Keywordsmacrophage / LPS / apoptosis / p38 MAP kinase / protein phosphorylation / cycloheximide / C3H / HeJ mouse / SB202190
Research Abstract

Continuation of phosphorylation but not the activation itself of p38 MAP kinase was shown to be one of the most important factors for the induction of macrophage apoptosis induced by lipopolysaccharide (LPS) in the presence of cycloheximide. Although it has widely been believed that phosphorylation of the kinase corresponds to the activation of this enzyme, we showed that SB202190, a potent and specific inhibitor of p38 MAP kinase, induced apototic cell death of macrophages in the presence of LPS, with complete inhibition of the kinase activity but with sustained phosphorylation of the kinase. These results suggest that LPS-induced (nacrophage apoptosis is closely linked to the regulation of phosphorylation of p38 MAP kinase, not through activation of the down-stream kinase cascades but rather through prolonged phosphorylation of the kinase and the presence of the phosphorylated kinase in the nucleus.
Another important result is the dissociation of the signaling pathways between apoptotic and activated macrophages. Refined procedures with pulse exposure of LPS to the macrophages in the presence or absence of serum and subsequent washing and reincubation of the cells revealed that as short as I min is enough to transduce the signals for the both apototic and activation processes of the macrophages, and that TLR4 and CD14 are involved in these processes, although later incubation than 30 min after LPS addition distinguish the signaling pathways either to the apoptosis or to the activation ; the former requires sustained phosphorylation of p38 MAP kinase by addition of cycloheximide or SB202190, as described above. Besides, the extents of CD14 expression was suggested to regulate the initial steps of the signal transduction.

  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] Karahashi, H., Amano, F.: "Changes of caspase activities involved in apoptosis of a macrophage-like cell line, J774.1/JA-4 treated with LPS and cycloheximide"Biol. Pharm. Bull. 23. 140-144 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Karahashi, H., Amano, F.: "Lipopolysaccharide (LPS)-induced cell death of C3H mouse peritoneal macrophages in the presence of cycloheximide : different susceptibilities of C3H/HeN and C3H/HeJ mice macrophages"J. Endotoxin Res.. 6. 33-39 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Karahashi, H., Nagata, K., Ishii, K., Amano, F.: "A selective inhibitor of p38 MAP kinase, SB202190, induced apoptotic cell death of a lipopolysaccharide(LPS)-treated macrophage-like cell line, J774.1"Biochim. Biophys. Acta. 1502. 207-223 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ikegami, R., Sugimoto, Y., Amano, F., Ichikawa, A.et al.: "The expression of prostaglandin E receptors EP2 and EP4 and their different regulation by lipopolysaccharide In C3H/HeN peritoneal macrophages"J. Immunol. 166. 4689-4696 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tanaka, Y., Igimi, S., Amano, F.: "Inhibition of prostaglandin synthesis by nitric oxide in RAW 264.7 macrophages"Arch. Biochem. Biophys. 391. 207-217 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ohki, K., Amano, F., Kohashi, O.: "Lipopolysaccharide (LPS) and zymosan-resistant mutant isolated from a macrophage-like cell line, WEHI-3, with a defectiveresponse to LPS under serum-free conditions"Immunol. Cell Biol.. 79. 462-471 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Karahashi, H., Amano, F.: "Changes of caspase activities involved in apoptosis of a macrophasge-like cell line, 774 1/JA-4 treated with LPS and cycloheximide"Biol. Pharm. Bull.. 23. 140-144 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Karahashi, H., Amano, F.: "Lipopolysaccharide (LPS)-induced cell death of C3H mouse peritoneal macrophages in the presence of cycloheximide : different susceptibilities of C3H/HeN and C3H/HeJ mice macrophages"J. Endotoxin Res. 6. 33-39 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Karahashi, H., Nagata, K, Ishii, k, Amano, F.: "A selective inhibitor of p38 MAP kinase, SB202190, induced apoptotic cell death of a lipopolysaccharide (LPS)-treated macrophage-like cell line, J774.1"Biochim. Biophys. Acta. 1502. 207-223 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ikegami, R., Sugimoto, Y., Segi, E., Katsuyama, M., Karahashi, H., Amano, F., Maruyama, T., Yamane, H., Tsuchiya, S., Ichikawa. A.: "The expression of prostaglandin E receptors EP2 and EP4 and their different regulatio by lipopolysaccharide in C3H/HeN peritoneal macrophages"J. Immunol. 166. 4689-4696 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tanaka, Y., Igimi, S., Amano, F.: "Inhibition of prostaglandin synthesis by nitric oxide in RAW 264.7 macrophages"Arch. Biochem. Biophys. 391. 207-217 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ohki, K., Amano, F., Kohashi, O.: "Lipopolysaccharide (LPS) and zymosan-resistant mutant isolated from a macrophage-like cell line, WEHI-3, with a defectiveresponse to LPS under serum-free conditions"immunol. Cell Biol. 79. 462-471 (2001)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2003-09-17  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi